Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis.

Lucie Andrés CerezoBarbora ŠumováKlára PrajzlerováDavid VeiglDres DamgaardClaus Henrik NielsenKarel PavelkaJiří VencovskýLadislav Šenolt

Published in: Arthritis research & therapy (2017)

Our data provide the first evidence of S100A11 up-regulation and its association with inflammation and disease activity in patients with RA.

Keyphrases